Quintiles and Allscripts have entered a strategic partnership to jointly develop software solutions to improve the drug development process and demonstrate the value of biopharma products.   The goal is to develop products that significantly reduce some of the bottlenecks associated with clinical research, outcomes, education and proof of new compound safety, effectiveness and value, according to a joint statement. Areas of focus include late-phase research, recruiting for and monitoring of clin...